Levetiracetam Stada Arzneimittel (Levetiracetam)

Levetiracetam binds selectively to the synaptic vesicle protein SV2A in the brain. This binding modulates neurotransmitter release, stabilises neuronal firing, and reduces hyper‑excitability, thereby decreasing the likelihood of seizure propagation.

The specific dose of levetiracetam is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, and seizure type. Dosage regimens are not standardized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and discuss these considerations with the patient. Breastfeeding decisions should also be made in consultation with a medical professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or valproate, levetiracetam has a relatively simple pharmacokinetic profile, fewer drug‑enzyme interactions, and is generally well tolerated. However, individual response varies, and the choice of therapy depends on seizure type, comorbidities and patient‑specific factors.

Levetiracetam tablets should be stored at temperatures below 25 °C in their original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity.

Levetiracetam is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless the formulation specifically allows it.

Serious adverse events include severe allergic reactions (e.g., anaphylaxis), skin disorders such as Stevens‑Johnson syndrome, blood dyscrasias, and psychiatric effects like depression, mood changes, or suicidal thoughts. Prompt medical attention is required if any of these occur.

Levetiracetam is contraindicated in individuals with a known hypersensitivity to the drug or any of its excipients. Patients with severe renal impairment may require special dosing considerations, and clinicians should evaluate suitability on a case‑by‑case basis.